Zhu B C, Fisher S F, Pande H, Calaycay J, Shively J E, Laine R A
J Biol Chem. 1984 Mar 25;259(6):3962-70.
Human placental fibronectin was isolated from fresh term placenta by urea extraction and purified by gelatin affinity chromatography. A 44-kDa chymotryptic fragment, also purified by gelatin affinity chromatography, gave a broad, diffuse band on polyacrylamide gel electrophoresis, whereas the analogous 43-kDa fragment from human plasma fibronectin migrated as a defined, narrow band. Upon extended treatment with endo-beta-galactosidase from Escherichia freundii, the 44-kDa chymotryptic gelatin-binding fragment from placental fibronectin changed its behavior on gel electrophoresis and migrated as a narrower, more defined band. The carbohydrates on human placental fibronectin contained a large percentage of polylactosamine structures, part of which occurred on the gelatin-binding fragment, comprising almost twice as much carbohydrate as plasma fibronectin. NH2-terminal amino acid sequence analysis of the chymotryptic gelatin-binding fragments from both fibronectins showed the first 21 residues to be identical. Tryptic and chymotryptic peptide maps of the gelatin-binding fragment from placental fibronectin, however, showed differences including several protease-resistant domains not found in the analogous fragment from plasma fibronectin. Intact placental fibronectin contains 20,000 Da of carbohydrate, whereas plasma fibronectin contains 11,000 Da. Placental fibronectin is more protease-resistant than plasma fibronectin, possibly due to the additional carbohydrate. Polyclonal antibodies against either fibronectin completely cross-react with amniotic fluid fibronectin, placental fibronectin, and plasma fibronectin upon Ouchterlony immunodiffusion. Human fibronectins of putatively the same polypeptide structure are, therefore, glycosylated in a dramatically different fashion, depending on the tissue of expression. If the patterns of glycosylation comprise the only difference in the glycoprotein, this may confer the characteristic protease resistance found for each of the fibronectins.
人胎盘纤连蛋白通过尿素提取从新鲜足月胎盘中分离出来,并通过明胶亲和层析进行纯化。一个44 kDa的胰凝乳蛋白酶片段,同样通过明胶亲和层析纯化,在聚丙烯酰胺凝胶电泳上呈现出一条宽的、弥散的条带,而来自人血浆纤连蛋白的类似43 kDa片段迁移为一条清晰、狭窄的条带。用来自弗氏埃希菌的内切β-半乳糖苷酶进行延长处理后,胎盘纤连蛋白的44 kDa胰凝乳蛋白酶明胶结合片段在凝胶电泳上改变了其行为,迁移为一条更窄、更清晰的条带。人胎盘纤连蛋白上的碳水化合物含有很大比例的多乳糖胺结构,其中一部分出现在明胶结合片段上,其碳水化合物含量几乎是血浆纤连蛋白的两倍。对两种纤连蛋白的胰凝乳蛋白酶明胶结合片段进行的NH2末端氨基酸序列分析表明,前21个残基是相同的。然而,胎盘纤连蛋白明胶结合片段的胰蛋白酶和胰凝乳蛋白酶肽图谱显示出差异,包括在血浆纤连蛋白的类似片段中未发现的几个抗蛋白酶结构域。完整的胎盘纤连蛋白含有20,000 Da的碳水化合物,而血浆纤连蛋白含有11,000 Da。胎盘纤连蛋白比血浆纤连蛋白更耐蛋白酶,这可能归因于额外的碳水化合物。在双向免疫扩散试验中,针对任何一种纤连蛋白的多克隆抗体与羊水纤连蛋白、胎盘纤连蛋白和血浆纤连蛋白完全交叉反应。因此,假定具有相同多肽结构的人纤连蛋白,根据表达组织的不同,其糖基化方式有显著差异。如果糖基化模式是糖蛋白中唯一的差异,那么这可能赋予了每种纤连蛋白所具有的特征性抗蛋白酶能力。